Status:
COMPLETED
Patients Overexposed for a Prostate Adenocarcinoma
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Prostate Adenocarcinoma
Eligibility:
MALE
18+ years
Brief Summary
Background: Between 2000 and 2006, 433 patients were overexposed (8% to 10%) during a course of conformal radiotherapy for a prostate adenocarcinoma in Jean MONNET hospital, Epinal, France. Among the...
Detailed Description
Secondary study endpoint: * Correlation between adverse events and radiation doses with biologic, phenotypic and genetic data. * Evaluation of T-lymphocyte apoptosis to predict radiation-induced late...
Eligibility Criteria
Inclusion
- provision of informed consent
- patient treated for prostate adenocarcinoma and overexposed during radiotherapy in a prostate adenocarcinoma in the radiation department of the a prostate adenocarcinoma in the radiation department of the Jean MONNET hospital/ service de radiotherapies between 2000 and 2006
Exclusion
- No provision of informed consent
- Patient with disease worsening and in incapacity to move about to CHJM
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
249 Patients enrolled
Trial Details
Trial ID
NCT00773656
Start Date
October 1 2008
End Date
May 1 2013
Last Update
February 27 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Pitié-Salpêtrière
Paris, France, 75013